Market Overview:
The global anti influenza virus Chinese medicine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of influenza and other respiratory infections, rising demand for traditional Chinese medicines, and growing awareness about the benefits of anti influenza virus Chinese medicines. The global anti influenza virus Chinese medicine market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into oral solution, capsule, lozenges chewable tablets aerosol injection pills particles syrup. On the basis of application,the market is segmented into adult children.Onthebasisofregion,.
Product Definition:
Anti Influenza Virus Chinese Medicine is a kind of traditional chinese medicine which has the function of anti influenza virus. It can improve the body's immunity and prevent from being infected by the influenza virus.
Oral Solution:
Oral solution is a preparation of herbal or natural ingredients dissolved in water and sugar. It can be consumed directly as a mouth wash or with food. The oral solutions are available in different forms such as syrups, tablets, liquids and powders. In traditional Chinese medicine (TCM), it is used to treat colds, sore throat, influenza (flu) viruses and other infections of the mouth & pharynx area including tonsillitis & adenoids.
Capsule:
The capsule is a small hollow container which contains the medicine. It is used to store the liquid or solid form of Chinese medicines. The size and shape of capsules vary according to their use. Capsules are widely used in traditional Chinese medicine for treating respiratory infections, digestive system disorders, pain relief and inflammation among others.
Application Insights:
Based on the application, the global market is segmented into adult and children. The adult segment held a larger share in 2017 owing to the fact that majority of people get infected with influenza A & B viruses every year. Influenza vaccination is mandatory for both adults as well as children to prevent from getting infected with this disease. According to WHO, approximately 60% of deaths caused by seasonal flu are among those aged 65 years and above which means that young as well as old people are susceptible to this disease. Therefore, demand for anti-influenza Chinese medicine will increase among these groups during upcoming seasons especially during winters when there is a rise in prevalence rate of respiratory diseases due largely to colds or infections caused by influenza virus amongst all age groups including kids and teenagers which will positively impact market growth over the forecast period.
Regional Analysis:
In terms of region, Asia Pacific dominated the global market in 2017. The presence of a large number of people suffering from chronic respiratory diseases owing to environmental pollution and unhealthy lifestyle is expected to drive the regional market over the forecast period. In addition, increasing disposable income levels and rising consumer awareness regarding alternative medicines are also likely to contribute towards growth during the same period.
The Chinese medicine industry in China witnessed significant growth due to its abundant supply of raw materials such as herbs and minerals along with skilled labor at low cost which attracted foreign investors for manufacturing these products leading to an increase in production capacity thereby driving down prices resulting into increased demand for these products among consumers. This factor is anticipated to have a positive impact on overall revenue generation over the next eight years.
Moreover, growing health concerns among consumers are expected boost product demand across this region as it provides relief from common cold symptoms such as runny nose, sneezing etc.
Growth Factors:
- Increasing awareness of the benefits of traditional Chinese medicine for treating influenza viruses.
- Growing demand from aging population for anti-influenza treatments.
- Rising number of people travelling to regions where influenza is endemic or outbreaks occur frequently.
Scope Of The Report
Report Attributes
Report Details
Report Title
Anti Influenza Virus Chinese Medicine Market Research Report
By Type
Oral Solution, Capsule, Lozenges, Chewable Tablets, Aerosol, Injection, Pills, Particles, Syrup
By Application
Adult, Children
By Companies
Guangzhou Pharmaceutical, CR SANJIU, TASLY, China TCM, Yunnan Baiyao, Tongrentang, Jumpcan, Zhejiang Conba Pharmaceutical, Green Valley Pharma, Changbaishan Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Qingfeng Pharmaceutical Group, Buchang Pharmaceutical, Livzon, ZBD Pharmaceutical, Chase Sun Pharmaceutical, Wuzhou Pharmaceutical, Yusheng Pharmaceutical, Harbin Pharmaceutical Group, Fusen Pharmaceutical, Gerun Pharmaceutical, Shineway Pharmaceutical, Yiling Pharmaceutical, Harbin Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Anti Influenza Virus Chinese Medicine Market Report Segments:
The global Anti Influenza Virus Chinese Medicine market is segmented on the basis of:
Types
Oral Solution, Capsule, Lozenges, Chewable Tablets, Aerosol, Injection, Pills, Particles, Syrup
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Guangzhou Pharmaceutical
- CR SANJIU
- TASLY
- China TCM
- Yunnan Baiyao
- Tongrentang
- Jumpcan
- Zhejiang Conba Pharmaceutical
- Green Valley Pharma
- Changbaishan Pharmaceutical
- Zhejiang Kanglaite Pharmaceutical
- Qingfeng Pharmaceutical Group
- Buchang Pharmaceutical
- Livzon
- ZBD Pharmaceutical
- Chase Sun Pharmaceutical
- Wuzhou Pharmaceutical
- Yusheng Pharmaceutical
- Harbin Pharmaceutical Group
- Fusen Pharmaceutical
- Gerun Pharmaceutical
- Shineway Pharmaceutical
- Yiling Pharmaceutical
- Harbin Pharmaceutical Group
Highlights of The Anti Influenza Virus Chinese Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Solution
- Capsule
- Lozenges
- Chewable Tablets
- Aerosol
- Injection
- Pills
- Particles
- Syrup
- By Application:
- Adult
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anti Influenza Virus Chinese Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anti-influenza virus Chinese medicine is a treatment approach that uses herbs, acupuncture, and other treatments to help reduce the symptoms of influenza.
Some of the major players in the anti influenza virus chinese medicine market are Guangzhou Pharmaceutical, CR SANJIU, TASLY, China TCM, Yunnan Baiyao, Tongrentang, Jumpcan, Zhejiang Conba Pharmaceutical, Green Valley Pharma, Changbaishan Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Qingfeng Pharmaceutical Group, Buchang Pharmaceutical, Livzon, ZBD Pharmaceutical, Chase Sun Pharmaceutical, Wuzhou Pharmaceutical, Yusheng Pharmaceutical, Harbin Pharmaceutical Group, Fusen Pharmaceutical, Gerun Pharmaceutical, Shineway Pharmaceutical, Yiling Pharmaceutical, Harbin Pharmaceutical Group.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anti Influenza Virus Chinese Medicine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anti Influenza Virus Chinese Medicine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anti Influenza Virus Chinese Medicine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anti Influenza Virus Chinese Medicine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anti Influenza Virus Chinese Medicine Market Size & Forecast, 2018-2028
4.5.1 Anti Influenza Virus Chinese Medicine Market Size and Y-o-Y Growth
4.5.2 Anti Influenza Virus Chinese Medicine Market Absolute $ Opportunity
Chapter 5 Global Anti Influenza Virus Chinese Medicine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anti Influenza Virus Chinese Medicine Market Size Forecast by Type
5.2.1 Oral Solution
5.2.2 Capsule
5.2.3 Lozenges
5.2.4 Chewable Tablets
5.2.5 Aerosol
5.2.6 Injection
5.2.7 Pills
5.2.8 Particles
5.2.9 Syrup
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anti Influenza Virus Chinese Medicine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anti Influenza Virus Chinese Medicine Market Size Forecast by Applications
6.2.1 Adult
6.2.2 Children
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anti Influenza Virus Chinese Medicine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anti Influenza Virus Chinese Medicine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anti Influenza Virus Chinese Medicine Analysis and Forecast
9.1 Introduction
9.2 North America Anti Influenza Virus Chinese Medicine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anti Influenza Virus Chinese Medicine Market Size Forecast by Type
9.6.1 Oral Solution
9.6.2 Capsule
9.6.3 Lozenges
9.6.4 Chewable Tablets
9.6.5 Aerosol
9.6.6 Injection
9.6.7 Pills
9.6.8 Particles
9.6.9 Syrup
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anti Influenza Virus Chinese Medicine Market Size Forecast by Applications
9.10.1 Adult
9.10.2 Children
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anti Influenza Virus Chinese Medicine Analysis and Forecast
10.1 Introduction
10.2 Europe Anti Influenza Virus Chinese Medicine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anti Influenza Virus Chinese Medicine Market Size Forecast by Type
10.6.1 Oral Solution
10.6.2 Capsule
10.6.3 Lozenges
10.6.4 Chewable Tablets
10.6.5 Aerosol
10.6.6 Injection
10.6.7 Pills
10.6.8 Particles
10.6.9 Syrup
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anti Influenza Virus Chinese Medicine Market Size Forecast by Applications
10.10.1 Adult
10.10.2 Children
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anti Influenza Virus Chinese Medicine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anti Influenza Virus Chinese Medicine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anti Influenza Virus Chinese Medicine Market Size Forecast by Type
11.6.1 Oral Solution
11.6.2 Capsule
11.6.3 Lozenges
11.6.4 Chewable Tablets
11.6.5 Aerosol
11.6.6 Injection
11.6.7 Pills
11.6.8 Particles
11.6.9 Syrup
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anti Influenza Virus Chinese Medicine Market Size Forecast by Applications
11.10.1 Adult
11.10.2 Children
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anti Influenza Virus Chinese Medicine Analysis and Forecast
12.1 Introduction
12.2 Latin America Anti Influenza Virus Chinese Medicine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anti Influenza Virus Chinese Medicine Market Size Forecast by Type
12.6.1 Oral Solution
12.6.2 Capsule
12.6.3 Lozenges
12.6.4 Chewable Tablets
12.6.5 Aerosol
12.6.6 Injection
12.6.7 Pills
12.6.8 Particles
12.6.9 Syrup
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anti Influenza Virus Chinese Medicine Market Size Forecast by Applications
12.10.1 Adult
12.10.2 Children
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anti Influenza Virus Chinese Medicine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anti Influenza Virus Chinese Medicine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anti Influenza Virus Chinese Medicine Market Size Forecast by Type
13.6.1 Oral Solution
13.6.2 Capsule
13.6.3 Lozenges
13.6.4 Chewable Tablets
13.6.5 Aerosol
13.6.6 Injection
13.6.7 Pills
13.6.8 Particles
13.6.9 Syrup
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anti Influenza Virus Chinese Medicine Market Size Forecast by Applications
13.10.1 Adult
13.10.2 Children
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anti Influenza Virus Chinese Medicine Market: Competitive Dashboard
14.2 Global Anti Influenza Virus Chinese Medicine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Guangzhou Pharmaceutical
14.3.2 CR SANJIU
14.3.3 TASLY
14.3.4 China TCM
14.3.5 Yunnan Baiyao
14.3.6 Tongrentang
14.3.7 Jumpcan
14.3.8 Zhejiang Conba Pharmaceutical
14.3.9 Green Valley Pharma
14.3.10 Changbaishan Pharmaceutical
14.3.11 Zhejiang Kanglaite Pharmaceutical
14.3.12 Qingfeng Pharmaceutical Group
14.3.13 Buchang Pharmaceutical
14.3.14 Livzon
14.3.15 ZBD Pharmaceutical
14.3.16 Chase Sun Pharmaceutical
14.3.17 Wuzhou Pharmaceutical
14.3.18 Yusheng Pharmaceutical
14.3.19 Harbin Pharmaceutical Group
14.3.20 Fusen Pharmaceutical
14.3.21 Gerun Pharmaceutical
14.3.22 Shineway Pharmaceutical
14.3.23 Yiling Pharmaceutical
14.3.24 Harbin Pharmaceutical Group
